AI-generated summary
This protocol describes a planned systematic review and meta-analysis of photobiomodulation therapy for ophthalmic diseases, including randomized and comparative nonrandomized trials. The authors plan to pool disease-specific outcomes and explore shared physiological measures, but the abstract reports no results. Findings are intended to generate hypotheses rather than determine optimal treatment.
- Who or what was studied
- Individuals with clinically diagnosed ophthalmic diseases, such as age-related macular degeneration, diabetic retinopathy, glaucoma, retinitis pigmentosa, and dry eye disease
- Limits stated in the abstract
- This is a protocol only, so no pooled effect estimates or study results are reported, and the abstract notes heterogeneity in study designs and outcome measures.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on systematicreviewsjournal.biomedcentral.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Photobiomodulation, Systematic review, Meta-analysis, Heterogeneity, Age-related macular degeneration, Oxidative stress, Near-infrared. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.